Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.
RELATED CONTENT
April 26, 2017 — A new report on the brain cancer diagnostics market projects that up to 78,000 new cases of primary ...
April 26, 2017 
Elekta announced that its Leksell Vantage Stereotactic System, will be highlighted at the American Association of Neurological Surgeons (AANS) Annual Meeting, April 22-26 in Los Angeles. Leksell Vantage is the company's next-generation system for target localization and coordinate referencing for precision neurosurgery. The system’s head frame is constructed of a novel epoxy composite and is designed to improve imaging quality, speed and patient comfort in neurosurgery procedures.
April 24, 2017 
Elekta announced new data demonstrating Leksell Gamma Knife better spares healthy brain tissue and delivers a higher radiation dose compared to linear accelerator (linac)-based delivery methods. The results, evaluating patients undergoing radiosurgery for large or complex brain tumors, were published in the Journal of Neurosurgery.
January 25, 2017 
On Dec. 8, 2016, a female patient in her 60s became the first in the Australia/New Zealand region to receive electronic brachytherapy to treat her skin cancer lesion, a basal cell carcinoma on her nose. Radiation Oncology Centres (ROC) physicians in Brisbane used their new Esteya electronic brachytherapy system from Elekta to deliver the patient’s first of six non-invasive treatments. Esteya is a form of high dose rate (HDR) brachytherapy that applies high-precision radiation therapy directly to the cancer site, reducing radiation to surrounding healthy tissues.
January 16, 2017 
The American Society for Radiation Oncology (ASTRO) announced in November that Elekta has provided signficant financial support to RO-ILS: Radiation Oncology Incident Learning System a national patient safety initiative launched in 2014 by ASTRO and the American Association of Physicists in Medicine (AAPM). RO-ILS facilitates safer and higher quality care in radiation oncology by providing a mechanism for shared learning in a secure and non-punitive environment. It is the only medical specialty society-sponsored radiation oncology incident learning system within a federally listed Patient Safety Organization (PSO).
December 13, 2016 
The American Society for Radiation Oncology (ASTRO) today announced an update to its Evidence-Based Consensus Statement for the use of Accelerated Partial Breast Irradiation (APBI) brachytherapy to include younger patients and those with low-risk ductal carcinoma in situ (DCIS).
November 22, 2016 
The Mayo Clinic defines radiation therapy as a type of cancer treatment that uses beams of intense energy to kill cancer cells, mostly getting its power from X-rays, but the power can also come from protons or other types of energy. Most often, it is in the form of external beam radiation therapy. In fact, according to the National Cancer Institute, more than half of all people with cancer receive radiation therapy as part of their treatment, making it one of the most common treatments for cancer.
November 01, 2016 Elekta introduced the Leksell Vantage Stereotactic System, its latest system for very precise neurosurgery, at the European Society for Stereotactic and Functional Neurosurgery (ESSFN) meeting, Sept. 28 – Oct. 1, in Madrid.
October 18, 2016 Elekta announced recently that its high-field magnetic resonance linear accelerator (MR-linac) was the focus of multiple presentations at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting, held Sept. 25 – 28 in Boston. Additional abstracts presented by members of Elekta’s MR-linac Consortium also highlighted the need for adaptation of radiation therapy to address moving tumors and nearby organs during treatment sessions. Naturally occurring physiological movements currently limit the ability to conform the treatment to the target and increase exposure of radiation to healthy tissues.
October 06, 2016 
Elekta announced that it has expanded its partnership with Radiating Hope, a volunteer organization that provides radiation equipment to resource-constrained countries. The organization also educates medical physics and radiation oncology personnel in those countries to help better serve their patient populations.
September 27, 2016